T. Lehtinen

423 total citations
18 papers, 274 citations indexed

About

T. Lehtinen is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, T. Lehtinen has authored 18 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in T. Lehtinen's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (3 papers). T. Lehtinen is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (3 papers). T. Lehtinen collaborates with scholars based in Finland, Sweden and Malaysia. T. Lehtinen's co-authors include Outi Kuittinen, Sirpa Leppä, T. Nousiainen, Kari Remes, Eeva Juvonen, Tom Wiklund, Matti Lehtinen, Joakim Dillner, Matti Putkonen and E. Koivunen and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

T. Lehtinen

17 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Lehtinen Finland 10 134 104 64 42 36 18 274
Musleh S. Tarawneh Jordan 10 107 0.8× 125 1.2× 37 0.6× 74 1.8× 21 0.6× 21 306
D Kamat United States 9 144 1.1× 122 1.2× 138 2.2× 57 1.4× 65 1.8× 17 410
Núbia Mendonça Brazil 7 146 1.1× 103 1.0× 27 0.4× 28 0.7× 79 2.2× 17 276
Mariëlle J. Wondergem Netherlands 12 96 0.7× 136 1.3× 58 0.9× 69 1.6× 23 0.6× 37 331
Ayumi Numata Japan 11 97 0.7× 78 0.8× 76 1.2× 53 1.3× 39 1.1× 38 310
Yasutaka Aoyama Japan 11 80 0.6× 44 0.4× 77 1.2× 46 1.1× 40 1.1× 43 294
Zeina Al‐Mansour United States 7 218 1.6× 96 0.9× 25 0.4× 61 1.5× 19 0.5× 20 319
T Iseki Japan 11 78 0.6× 62 0.6× 67 1.0× 46 1.1× 50 1.4× 20 320
Joanna Romejko‐Jarosińska Poland 8 127 0.9× 220 2.1× 44 0.7× 17 0.4× 78 2.2× 42 305
Hideyuki Kuwabara Japan 11 108 0.8× 122 1.2× 30 0.5× 57 1.4× 21 0.6× 29 300

Countries citing papers authored by T. Lehtinen

Since Specialization
Citations

This map shows the geographic impact of T. Lehtinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Lehtinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Lehtinen more than expected).

Fields of papers citing papers by T. Lehtinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Lehtinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Lehtinen. The network helps show where T. Lehtinen may publish in the future.

Co-authorship network of co-authors of T. Lehtinen

This figure shows the co-authorship network connecting the top 25 collaborators of T. Lehtinen. A scholar is included among the top collaborators of T. Lehtinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Lehtinen. T. Lehtinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Édouard, Pascal, Johan Lahti, Juha P. Ahtiainen, et al.. (2024). A musculoskeletal multifactorial individualised programme for hamstring muscle injury risk reduction in professional football: results of a prospective cohort study. BMJ Open Sport & Exercise Medicine. 10(1). e001866–e001866. 7 indexed citations
2.
Ikäheimo, Tiina M., T. Lehtinen, Riitta Antikaínen, et al.. (2013). Cold-related cardiorespiratory symptoms among subjects with and without hypertension: the National FINRISK Study 2002. European Journal of Public Health. 24(2). 237–243. 20 indexed citations
3.
Peltola, Jukka, Aki Hietaharju, Immo Rantala, T. Lehtinen, & Hannu Haapasalo. (2009). Case report A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease. Acta Neurologica Scandinavica. 98(5). 360–363. 7 indexed citations
4.
Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2006). Late non‐relapse mortality among adult autologous stem cell transplant recipients: a nation‐wide analysis of 1482 patients transplanted in 1990–2003. European Journal Of Haematology. 77(2). 114–119. 22 indexed citations
5.
Bloigu, Aini, Helga M. Ögmundsdóttir, Joakim Dillner, et al.. (2006). Activation of Maternal Epstein-Barr Virus Infection and Risk of Acute Leukemia in the Offspring. American Journal of Epidemiology. 165(2). 134–137. 25 indexed citations
6.
Jantunen, Esa, Maija Itälä, T. Lehtinen, et al.. (2006). Early treatment‐related mortality in adult autologous stem cell transplant recipients: a nation‐wide survey of 1482 transplanted patients. European Journal Of Haematology. 76(3). 245–250. 42 indexed citations
7.
Kuittinen, Taru, Tom Wiklund, Kari Remes, et al.. (2005). Outcome of progressive disease after autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a nation‐wide survey. European Journal Of Haematology. 75(3). 199–205. 8 indexed citations
8.
Jones, Gareth R., T. Lehtinen, F. E. Riphagen, & Reinhard von Roemeling. (2005). Adverse event (AE) reporting of oral clodronate with emphasis on osteonecrosis of the jaw. Journal of Clinical Oncology. 23(16_suppl). 799–799. 10 indexed citations
9.
Jantunen, Esa, Tom Wiklund, Eeva Juvonen, et al.. (2003). Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplantation. 33(4). 405–410. 56 indexed citations
10.
Lehtinen, T., Tapio Luostarinen, Joakim Dillner, et al.. (1996). Serum p53 accumulation and altered antibody responses to Epstein‐Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin. British Journal of Haematology. 93(1). 104–110. 10 indexed citations
11.
Cheng, H. M., et al.. (1995). The disease associations of the antibody response against the Epstein--Barr virus transactivator protein ZEBRA can be separated into different epitopes. Journal of General Virology. 76(6). 1393–1400. 21 indexed citations
12.
Lähdeaho, Marja‐Leena, et al.. (1994). Antibody response to adenovirus Elb‐derived synthetic peptides and serum levels of p53 in patients with gastrointestinal and other malignant lymphomas. Journal of Medical Virology. 43(4). 393–396. 3 indexed citations
13.
Lehtinen, T., Matti Lehtinen, Risto Aine, et al.. (1989). Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.. Journal of Clinical Pathology. 42(7). 699–704. 4 indexed citations
14.
Lehtinen, T.. (1988). Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.. PubMed. 12(1-6). 125–31. 7 indexed citations
15.
Lehtinen, T., Matti Lehtinen, Risto Aine, et al.. (1987). Nuclear DNA content of non-endemic Burkitt's lymphoma.. Journal of Clinical Pathology. 40(10). 1201–1205. 14 indexed citations
16.
Lehtinen, Matti, et al.. (1987). Expression of the HSV specified major DNA-binding protein in virus infected RAJI and VERO cells. Archives of Virology. 94(1-2). 71–79. 3 indexed citations
17.
Lehtinen, Matti, Immo Rantala, Klaus Teisala, et al.. (1985). Detection of Herpes Simplex Virus in Women with Acute Pelvic Inflammatory Disease. The Journal of Infectious Diseases. 152(1). 78–82. 14 indexed citations
18.
Lehtinen, Matti, et al.. (1984). Purification of herpes simplex virus-specified major DNA-binding proteins and detection of antibodies to them in human and rabbit sera.. PubMed. 28(6). 449–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Musleh S. Tarawneh Breakdown of academic impact, for papers by D Kamat Breakdown of academic impact, for papers by Núbia Mendonça Breakdown of academic impact, for papers by Mariëlle J. Wondergem Breakdown of academic impact, for papers by Ayumi Numata Breakdown of academic impact, for papers by Yasutaka Aoyama Breakdown of academic impact, for papers by Zeina Al‐Mansour Breakdown of academic impact, for papers by T Iseki Breakdown of academic impact, for papers by Joanna Romejko‐Jarosińska Breakdown of academic impact, for papers by Hideyuki Kuwabara
Rankless by CCL
2026